Plus a great piece from ICER founder Steve Pearson on why price isn't (always) the problem
And a JAMA Forum paper makes a weird case for more price regulation
We've got news on IRA, obesity, PDABs, 340B, IP, and lots, lots more ... something for everyone
It's a grab bag today: insulin, NHE projections, and obesity-med coverage are on my mind
And a hint that United might be launching a pseudo drug company
And additional background on Trump-era insulin policies
And it's possible that the politics of insulin are going to get even dumber
And what's the right price for the med Shkreli made famous? (Hint: it's somewhere between $17 and $750 a pill)
And a long (but still incomplete!) list of events I'm watching for this summer
I'm celebrating by writing a few hundred words on what the last 200 or so newsletters have taught me
And Cuban on the PBM campaign: 'so bad they will be ignored and forgotten quickly'
Plus more thinking on the next set of price-controlled meds
